Skanefresko Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 9.09%
(FY 2022)
- Profit 50.00%
(FY 2022)
- Ebitda 50.00%
(FY 2022)
- Net Worth 1.75%
(FY 2022)
- Total Assets 1.63%
(FY 2022)
About Skanefresko Lifesciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tapkire Sudhir and Shrikant Rajurkar serve as directors at the Company.
- CIN/LLPIN
U24239PN2019PTC186700
- Company No.
186700
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skanefresko Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tapkire Sudhir  | Director | 17-Sep-2019 | Current |
| Shrikant Rajurkar | Director | 17-Sep-2019 | Current |
Financial Performance of Skanefresko Lifesciences.
Skanefresko Lifesciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.09% increase. The company also saw a substantial improvement in profitability, with a 50% increase in profit. The company's net worth moved up by a moderate rise of 1.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skanefresko Lifesciences?
Unlock access to Skanefresko Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skanefresko Lifesciences?
Unlock and access historical data on people associated with Skanefresko Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skanefresko Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skanefresko Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
